Free Trial
CVE:QPT

Quest PharmaTech (QPT) Stock Price, News & Analysis

Quest PharmaTech logo
C$0.03
+0.01 (+20.00%)
(As of 11/1/2024 05:43 PM ET)

About Quest PharmaTech Stock (CVE:QPT)

Key Stats

Today's Range
C$0.03
C$0.03
50-Day Range
C$0.02
C$0.04
52-Week Range
C$0.02
C$0.07
Volume
18,000 shs
Average Volume
65,000 shs
Market Capitalization
C$5.07 million
P/E Ratio
N/A
Dividend Yield
6.15%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Receive QPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter.

QPT Stock News Headlines

Quest PharmaTech Inc (QPT)
Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Quest PharmaTech Announces Results from AGM
See More Headlines

QPT Stock Analysis - Frequently Asked Questions

Quest PharmaTech's stock was trading at C$0.06 at the beginning of the year. Since then, QPT stock has decreased by 45.5% and is now trading at C$0.03.
View the best growth stocks for 2024 here
.

Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athenex (ATNX), Athersys (ATHX) and Antibe Therapeutics (ATE).

Company Calendar

Today
11/04/2024
Next Earnings (Estimated)
12/11/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Net Income
C$-2,880,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$38,871.00
Cash Flow
C$0.00 per share
Book Value
C$0.14 per share

Miscellaneous

Free Float
N/A
Market Cap
C$5.07 million
Optionable
Not Optionable
Beta
0.14
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (CVE:QPT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners